Skip to main content
. Author manuscript; available in PMC: 2013 Aug 6.
Published in final edited form as: Breast Cancer Res Treat. 2012 Aug 3;135(2):571–580. doi: 10.1007/s10549-012-2185-3

Table 1.

Descriptive characteristics of breast cancer cases and controls by race

Variable All women
Whites
African Americans
Cases Controls Cases Controls Cases Controls
No of subjects 491 528 297 324 194 204
Mean age (CBCS), yearsa 53.2 (28–74) 54.0 (31–74) 53.9 (28–74) 54.5 (35–74) 52.0 (30–74) 53.3 (31–74)
Mean age (CMR), yearsb 53.2 (28–77) 54.5 (34–76) 53.9 (28–77) 54.8 (35–76) 52.0 (30–74) 53.9 (34–76)
Mean BMIb 28.6 (15.1, 60.6) 28.8 (14.6, 60.9) 26.5 (17.2, 49.5) 26.8 (16.2, 52.9) 32.0 (15.1, 60.6) 32.1 (14.6, 60.9)
Mean number of daysc −21 (−1401, 365) 149 (−1617, 1095) −29 (−1401, 365) 133 (−1526, 1095) −9 (−1210, 365) 175 (−1617, 1078)
Breast density
  Almost entirely fat 13 (2.7 %) 25 (4.7 %) 5 (1.7 %) 10 (3.1 %) 8 (4.1 %) 15 (7.4 %)
  Scattered fibroglandular densities 183 (37.3 %) 197 (37.3 %) 98 (33.0 %) 108 (33.3 %) 85 (43.8 %) 89 (43.6 %)
  Heterogeneously dense 232 (47.3 %) 253 (47.9 %) 144 (48.5 %) 171 (52.8 %) 88 (45.4 %) 82 (40.2 %)
  Extremely dense 63 (12.8 %) 53 (10.0 %) 50 (16.8 %) 35 (10.8 %) 13 (6.7 %) 18 (8.8 %)
Menopausal status
  Premenopausal 200 (40.7 %) 213 (40.3 %) 120 (40.4 %) 127 (39.2 %) 80 (41.2 %) 86 (42.2 %)
  Postmenopausal 291 (59.3 %) 315 (59.7 %) 177 (59.6 %) 197 (60.8 %) 114(58.8 %) 118 (57.8 %)
Family historyd
  No 386 (81.1 %) 440 (85.6 %) 232 (80.1 %) 263 (83.0 %) 154 (82.4 %) 177 (89.9 %)
  Yes 90 (18.9 %) 74 (14.4 %) 57 (19.7 %) 54 (17.0 %) 33 (17.6 %) 20 (10.2 %)
  Missingf 15 14 8 7 7 7
Age at menarche
  <13 257 (52.3 %) 230 (43.6 %) 148 (49.8 %) 135 (41.7 %) 109 (56.2 %) 95 (46.6 %)
  ≥13 234 (47.7 %) 298 (56.4 %) 149 (50.2 %) 189 (58.3 %) 85 (43.8 %) 109 (53.4 %)
Parity and age at FFTPe
  Nulliparous 74 (15.1 %) 67 (12.7 %) 39 (13.1 %) 45 (13.9 %) 35 (18.0 %) 22 (10.8 %)
  Parous, <26 312 (63.5 %) 347 (65.7 %) 178 (59.9 %) 200 (61.7 %) 134 (69.1 %) 147 (72.1 %)
  Parous 26+ 105 (21.4 %) 114 (21.6 %) 80 (26.9 %) 79 (24.4 %) 25 (12.9 %) 35 (17.2 %)
Breastfeeding
  Never 299 (60.9 %) 324 (61.4 %) 163 (54.9 %) 201 (62.0 %) 136 (70.1 %) 123 (60.3 %)
  Ever 192 (39.1 %) 204 (38.6 %) 134 (45.1 %) 123 (38.0 %) 58 (29.9 %) 81 (39.7 %)
Lifetime duration lactation
  Never 299 (60.9 %) 324 (61.4 %) 163 (54.9 %) 201 (62.0 %) 136 (70.1 %) 123 (60.2 %)
  >0–3 months 72 (14.7 %) 69 (13.1 %) 58 (19.5 %) 45 (13.9 %) 14 (7.2 %) 24 (11.8 %)
  4+ months 120 (24.4 %) 135 (25.6 %) 76 (25.6 %) 78 (24.1 %) 44 (22.7 %) 57 (27.9 %)
Current HT use at the time of the mammogram
  No 359 (73.6 %) 336 (65.0 %) 193 (65.4 %) 182 (57.2 %) 166 (86.1 %) 154 (77.4 %)
  Yes 129 (26.4 %) 181 (35.1 %) 102 (34.6 %) 136 (42.8 %) 27 (14.0 %) 45 (22.6 %)
  Missingf 3 11 2 6 1 5
Oral contraceptive use
  Never 170 (34.6 %) 170 (32.4 %) 95 (32.0 %) 89 (27.6 %) 75 (38.7 %) 81 (39.9 %)
  Ever 321 (65.4 %) 355 (67.6 %) 202 (68.0 %) 233 (72.4 %) 119 (61.3 %) 122 (60.1 %)
  Missingf 0 3 0 2 0 1
WHRe
    <0.77 132 (27.3 %) 169 (32.3 %) 110 (37.2%) 133 (41.3 %) 22(11.7 %) 36 (17.8 %)
    0.77–0.83 171 (35.3 %) 173 (33.0 %) 110 (37.2%) 105 (32.6 %) 61 (32.5 %) 68 (33.7 %)
    ≥0.84 181 (37.4 %) 182 (34.7 %) 76 (25.7 %) 84 (26.1 %) 105 (55.9 %) 98 (48.5 %)
Missingf 7 4 1 2 6 2
a

Mean (range) age at diagnosis for cases and selection for controls in the CBCS

b

Mean (range) age at the time of the mammogram in the CMR

c

Mean (range) number of days between diagnosis date for cases and selection date for controls in the CBCS and the date of the mammogram chosen to assess breast density

d

First-degree family history of breast cancer

e

FFTP first full-term pregnancy, WHR waist-to-hip ratio

f

Missing values were excluded from percentage calculations